Evaluation and Prediction of Treatment Response for Hepatocellular Carcinoma

The incidence of hepatocellular carcinoma (HCC) is still on the rise in North America and Europe and is the second leading cause of cancer-related mortality. The treatment of HCC varies, with surgery and locoregional therapy (LRT) such as radiofrequency ablation and transcatheter arterial chemoembol...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsujita, Yushi, Sofue, Keitaro, Ueshima, Eisuke, Ueno, Yoshiko, Hori, Masatoshi, Tsurusaki, Masakatsu, Murakami, Takamichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Magnetic Resonance in Medicine 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086401/
https://www.ncbi.nlm.nih.gov/pubmed/36792205
http://dx.doi.org/10.2463/mrms.rev.2022-0118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086401/
https://www.ncbi.nlm.nih.gov/pubmed/36792205
http://dx.doi.org/10.2463/mrms.rev.2022-0118

Ejemplares similares